Question of the Day

Question of the Day – Friday February 22, 2019

Question – Methotrexate administered to pediatric patients, including infants and adolescents, may result in long-term cognitive impairments (including memory impairment, attention and executive function deficits). What percentage of survivors of childhood leukemia treated with methotrexate will experience result in long-term cognitive impairments?

View full post for answer.

Question of the Day – Wednesday February 13, 2019

Question – The perfluoroalkyl compounds PFOA and PFOS are no longer manufactured or imported into the United States. What has happened to serum levels of these compounds in the general U.S. population, in part, as a result of the discontinuation of manufacture and importation of these chemicals?

View full post for answer.